ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 232

$1.16M Total Retail Price of All Prescriptions

Rank: 9 out of 232

664 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
FUROSEMIDE 562 520 1 7
LEVOTHYROXINE SODIUM 537 488 2 3
SIMVASTATIN 497 481 3 1
NAMENDA 496 496 4 18
AMLODIPINE BESYLATE 397 362 5 2
DONEPEZIL HCL 378 361 6 13
WARFARIN SODIUM 373 304 7 8
EXELON 316 307 8 95
ESCITALOPRAM OXALATE 305 291 9 54
OMEPRAZOLE 294 264 10 4
LISINOPRIL 270 250 11 6
METFORMIN HCL 230 208 12 9
GABAPENTIN 216 150 13 12
MIRTAZAPINE 210 210 14 28
DIOVAN 202 201 15 27
LIDODERM 202 169 15 48
METOPROLOL TARTRATE 199 176 17 10
HYDROCHLOROTHIAZIDE 183 175 18 16
RISPERIDONE 182 147 19 42
HYDROCODONE-ACETAMINOPHEN 176 168 S3 20 5
METOPROLOL SUCCINATE 175 169 21 23
CARVEDILOL 173 156 22 21
TRAMADOL HCL 173 157 22 33
CITALOPRAM HBR 169 151 24 24
PANTOPRAZOLE SODIUM 161 147 25 26
ATORVASTATIN CALCIUM 160 146 26 14
ZOLPIDEM TARTRATE 159 144 27 19
FAMOTIDINE 149 131 28 30
QUETIAPINE FUMARATE 142 136 29 41
TRAZODONE HCL 138 124 30 38
CIPROFLOXACIN HCL 132 100 31 68
ATENOLOL 128 128 32 11
ALENDRONATE SODIUM 123 123 33 17
DIVALPROEX SODIUM 121 113 34 47
DIGOXIN 121 121 34 37
JANUVIA 121 116 34 60
POTASSIUM CHLORIDE 116 102 37 20
FLUTICASONE PROPIONATE 113 108 38 43
SERTRALINE HCL 110 106 39 35
OLANZAPINE 107 106 40 86
LEXAPRO 106 96 41 170
GLIPIZIDE 106 102 41 29
TAMSULOSIN HCL 96 82 43 22
ENOXAPARIN SODIUM 90 54 44 250
LOSARTAN POTASSIUM 86 70 45 15
LANTUS 81 46 46 36
CLOPIDOGREL 76 69 47 34
DOXAZOSIN MESYLATE 76 76 47 99
LOVAZA 76 76 47 166
ALLOPURINOL 74 71 50 39
PAROXETINE HCL 74 73 50 69
AZITHROMYCIN 72 62 52 51
CLOTRIMAZOLE-BETAMETHASONE 71 69 53 195
LEVETIRACETAM 68 51 54 72
ZETIA 64 64 55 136
DIOVAN HCT 63 63 56 53
BACLOFEN 62 45 57 83
MELOXICAM 62 46 57 55
LEVOFLOXACIN 61 56 59 80
CRESTOR 60 60 60 56
PRAVASTATIN SODIUM 59 56 61 32
HYDRALAZINE HCL 59 55 61 62
CELEBREX 58 56 63 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 55 63 111
FENTANYL 56 25 S2 65 115
GALANTAMINE HBR 55 55 66 186
CYMBALTA 54 19 67 57
NOVOLIN R 52 43 68 74
OXYCODONE-ACETAMINOPHEN 50 24 S2 69 109
LATANOPROST 50 48 69 244
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.